资讯
Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...
Zacks Investment Research on MSN
REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock?
Shares of Regeneron Pharmaceuticals (REGN) have lost 21.1% year to date against the industry’s growth of 5.2%. The stock has ...
In-vitro toxicology testing market was valued at US$ 26.00 billion in 2024 and is projected to hit the market valuation of US$ 57.55 billion by 2033 at a CAGR of 9.23% during the forecast period ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果